Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma

2020/11/26 by Changrong Wang, Xiaoguang Shi, Huijuan Song +7 · 1 citation
Immunology and Microbiology · Medicine · Biochemistry, Genetics and Molecular Biology · #Immunotherapy and Immune Responses #CAR-T cell therapy research #RNA Interference and Gene Delivery

paper · doi:10.1016/j.biomaterials.2020.120579

Citations

• Tumour heterogeneity and cancer cell plasticity
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
• Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
• Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Cited by

• Recent Advances in Tetrahedral Framework Nucleic Acids for Multimodal Synergistic Cancer Therapy